BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 21732757)

  • 21. Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.
    Pilati P; Mocellin S; Bertazza L; Galdi F; Briarava M; Mammano E; Tessari E; Zavagno G; Nitti D
    Ann Surg Oncol; 2012 Feb; 19(2):402-8. PubMed ID: 22071867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating tumour cells--a bona fide cause of metastatic cancer.
    Caixeiro NJ; Kienzle N; Lim SH; Spring KJ; Tognela A; Scott KF; de Souza P; Becker TM
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):747-56. PubMed ID: 24817039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R; Daniele A; Savino E; Palma F; Bellizzi A; Giotta F; Simone G; Lioce M; Quaranta M; Paradiso A; Mazzocca A
    Anticancer Res; 2013 Apr; 33(4):1491-7. PubMed ID: 23564790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumor cells: detection, molecular profiling and future prospects.
    Jacob K; Sollier C; Jabado N
    Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
    Ignatiadis M; Lee M; Jeffrey SS
    Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells.
    Hayes DF; Smerage JB
    Prog Mol Biol Transl Sci; 2010; 95():95-112. PubMed ID: 21075330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversies in circulating tumor cell count during therapy.
    Raimondi C; Gradilone A; Gazzaniga P
    Expert Rev Mol Diagn; 2013 Jun; 13(5):499-507. PubMed ID: 23782256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biology, detection, and clinical implications of circulating tumor cells.
    Joosse SA; Gorges TM; Pantel K
    EMBO Mol Med; 2015 Jan; 7(1):1-11. PubMed ID: 25398926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating cancer cells are potential weapon for future generations.
    Dobrila-Dintinjana R
    Hepatogastroenterology; 2014; 61(129):5-8. PubMed ID: 24895783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Tumor Cells as Cancer Biomarkers in the Clinic.
    Chinen LTD; Abdallah EA; Braun AC; Flores BCTCP; Corassa M; Sanches SM; Fanelli MF
    Adv Exp Med Biol; 2017; 994():1-41. PubMed ID: 28560666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.
    Sieuwerts AM; Mostert B; Bolt-de Vries J; Peeters D; de Jongh FE; Stouthard JM; Dirix LY; van Dam PA; Van Galen A; de Weerd V; Kraan J; van der Spoel P; Ramírez-Moreno R; van Deurzen CH; Smid M; Yu JX; Jiang J; Wang Y; Gratama JW; Sleijfer S; Foekens JA; Martens JW
    Clin Cancer Res; 2011 Jun; 17(11):3600-18. PubMed ID: 21505063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
    Joosse SA; Pantel K
    Cancer Metastasis Rev; 2016 Mar; 35(1):41-8. PubMed ID: 26931653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microfluidics and circulating tumor cells.
    Dong Y; Skelley AM; Merdek KD; Sprott KM; Jiang C; Pierceall WE; Lin J; Stocum M; Carney WP; Smirnov DA
    J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases.
    Giesing M; Driesel G; Molitor D; Suchy B
    BJU Int; 2012 Dec; 110(11 Pt C):E1202-11. PubMed ID: 23046102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating tumor cells (CTCs) as a liquid biopsy material and drug target.
    Cai LL; Ye HM; Zheng LM; Ruan RS; Tzeng CM
    Curr Drug Targets; 2014; 15(10):965-72. PubMed ID: 25182470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advanced technologies for studying circulating tumor cells at the protein level.
    Chan CM; Au TC; Chan AT; Ma BB; Tsui NB; Ng SS; Hui EP; Chan LW; Ho WS; Yung BY; Wong SC
    Expert Rev Proteomics; 2013 Dec; 10(6):579-89. PubMed ID: 24206230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of circulating tumor cells in primary and metastatic breast cancer.
    Aurilio G; Sciandivasci A; Munzone E; Sandri MT; Zorzino L; Cassatella MC; Verri E; Rocca MC; Nolè F
    Expert Rev Anticancer Ther; 2012 Feb; 12(2):203-14. PubMed ID: 22316368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating tumour cells in cancer patients: challenges and perspectives.
    Pantel K; Alix-Panabières C
    Trends Mol Med; 2010 Sep; 16(9):398-406. PubMed ID: 20667783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
    Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
    Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumor cells: the 'leukemic phase' of solid cancers.
    Mocellin S; Keilholz U; Rossi CR; Nitti D
    Trends Mol Med; 2006 Mar; 12(3):130-9. PubMed ID: 16488189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.